Man Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.7M | Sell |
184,177
-270,971
| -60% | -$9.85M | 0.01% | 792 |
|
2025
Q1 | $16.5M | Buy |
455,148
+157,754
| +53% | +$5.71M | 0.04% | 445 |
|
2024
Q4 | $12.5M | Sell |
297,394
-29,809
| -9% | -$1.25M | 0.03% | 550 |
|
2024
Q3 | $18.2M | Sell |
327,203
-301,523
| -48% | -$16.7M | 0.05% | 443 |
|
2024
Q2 | $25.8M | Buy |
628,726
+475,085
| +309% | +$19.5M | 0.07% | 344 |
|
2024
Q1 | $7.17M | Buy |
153,641
+65,830
| +75% | +$3.07M | 0.02% | 798 |
|
2023
Q4 | $4.2M | Buy |
+87,811
| New | +$4.2M | 0.01% | 951 |
|
2023
Q3 | – | Sell |
-42,277
| Closed | -$1.95M | – | 1364 |
|
2023
Q2 | $1.95M | Buy |
+42,277
| New | +$1.95M | 0.01% | 1189 |
|
2023
Q1 | – | Sell |
-38,211
| Closed | -$1.77M | – | 1391 |
|
2022
Q4 | $1.77M | Buy |
38,211
+3,773
| +11% | +$175K | 0.01% | 1149 |
|
2022
Q3 | $1.43M | Buy |
+34,438
| New | +$1.43M | 0.01% | 1158 |
|
2022
Q2 | – | Sell |
-6,724
| Closed | -$488K | – | 1202 |
|
2022
Q1 | $488K | Buy |
+6,724
| New | +$488K | ﹤0.01% | 1567 |
|
2021
Q2 | – | Sell |
-16,645
| Closed | -$1.9M | – | 1987 |
|
2021
Q1 | $1.9M | Sell |
16,645
-28,503
| -63% | -$3.25M | 0.01% | 1125 |
|
2020
Q4 | $6.25M | Buy |
45,148
+12,555
| +39% | +$1.74M | 0.03% | 674 |
|
2020
Q3 | $2.68M | Buy |
32,593
+4,016
| +14% | +$330K | 0.01% | 1088 |
|
2020
Q2 | $2.24M | Sell |
28,577
-8,771
| -23% | -$686K | 0.01% | 1021 |
|
2020
Q1 | $1.66M | Sell |
37,348
-58,795
| -61% | -$2.61M | 0.01% | 957 |
|
2019
Q4 | $4.11M | Buy |
96,143
+44,797
| +87% | +$1.91M | 0.01% | 1062 |
|
2019
Q3 | $2.2M | Sell |
51,346
-16,217
| -24% | -$694K | 0.01% | 1206 |
|
2019
Q2 | $4.29M | Sell |
67,563
-10,142
| -13% | -$644K | 0.02% | 1010 |
|
2019
Q1 | $5.39M | Buy |
77,705
+34,662
| +81% | +$2.4M | 0.02% | 873 |
|
2018
Q4 | $1.87M | Sell |
43,043
-6,341
| -13% | -$276K | 0.01% | 1238 |
|
2018
Q3 | $3.77M | Buy |
+49,384
| New | +$3.77M | 0.01% | 1136 |
|